Literature DB >> 7000828

Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat.

S R Winternitz, R E Katholi, S Oparil.   

Abstract

Neurogenic factors and, in particular, enhanced renal sympathetic tone, have been implicated in the pathogenesis of hypertension in the spontaneously hypertensive rat of the Okamoto strain. To examine the hypothesis that the renal sympathetic nerves contribute to the development and maintenance of hypertension by causing urinary sodium retention, 7-wk-old (early hypertensive) and 18-wk-old (established hypertensive) male spontaneously hypertensive rats were subjected to bilateral renal denervation and compared with sham-operated controls. In 7-wk-old animals renal denervation delayed the onset and slowed the rate of development of hypertension. These alterations were associated with a significantly greater fractional excretion of sodium (percentage of sodium intake excreted) during the first 3 wk after denervation. Blood pressure 2 wk after surgery was 169+/-3.5 (sham) vs. 150+/-2.4 mm Hg (denervated) (P < 0.001), corresponding to fractional sodium excretions of 65+/-1.3% (sham) vs. 80+/-2.3% (denervated) (P < 0.001). By the 5th wk after surgery, at which time an increase in renal norepinephrine content of denervated animals suggested reinnervation, blood pressures in the two groups converged (sham, 199+/-6.5 mm Hg vs. denervated 180+/-3.5 mm Hg, NS) and there was no difference in sodium excretion (sham, 77+/-2.5% vs. denervated 79+/-2.3%). Plasma and kidney renin activity of denervated animals did not differ significantly from that of sham-operated controls. In 18-wk-old rats renal denervation did not alter blood pressure or urinary sodium excretion. These data indicate that the renal sympathetic nerves contribute to the development of hypertension in the spontaneously hypertensive rat in part by causing enhanced sodium retention. Once hypertension is established the renal nerves do not play a significant role in the maintenance of increased blood pressure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000828      PMCID: PMC371533          DOI: 10.1172/JCI109966

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Effects of adrenergic nervous system and catecholamines on systemic and renal hemodynamics, sodium and water excretion and renin secretion.

Authors:  R W Schrier
Journal:  Kidney Int       Date:  1974-11       Impact factor: 10.612

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

3.  A micromethod for measurement of renin in the plasma and kidney of rats.

Authors:  R Boucher; J Ménard; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1967-09       Impact factor: 2.273

Review 4.  Control of renin release.

Authors:  A J Vander
Journal:  Physiol Rev       Date:  1967-07       Impact factor: 37.312

5.  Central adrenergic neurones and the initiation and development of experimental hypertension.

Authors:  G Haeusler; L Finch; H Thoenen
Journal:  Experientia       Date:  1972-10-15

6.  Renal vascular resistance in spontaneously hypertensive rats.

Authors:  B Folkow; M Hallbäck; Y Lundgren; L Weiss
Journal:  Acta Physiol Scand       Date:  1971-09

7.  Structurally based increase of flow resistance in spontaneously hypertensive rats.

Authors:  B Folkow; M Hallbäck; Y Lundgren; L Weiss
Journal:  Acta Physiol Scand       Date:  1970-07

8.  Renal innervation and renin activity in salt metabolism and hypertension.

Authors:  R A Mogil; H D Itskovitz; J H Russell; J J Murphy
Journal:  Am J Physiol       Date:  1969-04

9.  Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine.

Authors:  R A Nadeau; J de Champlain; G M Tremblay
Journal:  Can J Physiol Pharmacol       Date:  1971-01       Impact factor: 2.273

10.  Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat.

Authors:  K Okamoto; S Nosaka; Y Yamori; M Matsumoto
Journal:  Jpn Heart J       Date:  1967-03
View more
  33 in total

Review 1.  Renal afferents and hypertension.

Authors:  John Ciriello; Cleusa V R de Oliveira
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

4.  Can catheter-based renal denervation be used safely and effectively to substantially reduce blood pressure in treatment-resistant hypertensive patients?

Authors:  Suzanne Oparil
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

5.  Renal denervation and CD161a immune ablation prevent cholinergic hypertension and renal sodium retention.

Authors:  Nandita Raikwar; Cameron Braverman; Peter M Snyder; Robert A Fenton; David K Meyerholz; Francois M Abboud; Sailesh C Harwani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-07       Impact factor: 4.733

6.  Renal and hormonal effects of alpha 1-adrenoceptor blockade by bunazosin in essential hypertension.

Authors:  Y Hirata; K Fukui; Y Dan; H Matsuoka; T Sugimoto; M Ishii
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  123I-mIBG scintigraphy: Clinical tool for assessing renal sympathetic activity?

Authors:  Christopher George; Pradeep G Bhambhvani; Suzanne Oparil
Journal:  J Nucl Cardiol       Date:  2016-12-30       Impact factor: 5.952

Review 8.  Pressure natriuresis and the renal control of arterial blood pressure.

Authors:  Jessica R Ivy; Matthew A Bailey
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

Review 9.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

10.  Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.

Authors:  Kazunari Nohara; Rizwana S Waraich; Suhuan Liu; Mathieu Ferron; Aurélie Waget; Matthew S Meyers; Gérard Karsenty; Rémy Burcelin; Franck Mauvais-Jarvis
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-23       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.